• xoma completes sale of kinnate pipeline assets for up to $270m TipRanks Mon, 14 Apr 2025 23:17:01 GMT

• xoma completes sale of kinnate assets for up to $270 million Investing.com India Mon, 14 Apr 2025 12:07:47 GMT

• XOMA Royalty Completes Sale of Kinnate Pipeline Assets GlobeNewswire Mon, 14 Apr 2025 07:00:00 GMT

• kinnate biopharma divulges new mek inhibitors BioWorld MedTech Tue, 01 Apr 2025 07:00:00 GMT

• intrahepatic cholangiocarcinoma pipeline insights 2024: therapies, clinical trials, and key companies involved by delveinsight | x... The Globe and Mail Fri, 20 Dec 2024 20:50:07 GMT

• intrahepatic cholangiocarcinoma pipeline update 2024: fda approvals, therapeutic advancements, and key companies involved by delve... Barchart Tue, 29 Oct 2024 07:00:00 GMT

• Eric Murphy, Ph.D., Co-Founder and CEO of Alterome, Named to Goldman Sachs Top 100 Most Exceptional Entrepreneurs at 2024 Builders... BioSpace Fri, 18 Oct 2024 07:00:00 GMT

• xoma to acquire kinnate biopharma for $2.3352 - $2.5879 per share MSN Tue, 15 Oct 2024 06:48:16 GMT

• kinnate biopharma sells rights of exarafenib to pierre fabre laboratories MSN Tue, 08 Oct 2024 22:27:24 GMT

• a closer look at knife river corp (knf)’s stock price trends US Post News Fri, 20 Sep 2024 14:44:38 GMT

• kintara therapeutics announces adjournment of special meeting of stockholders until october 4, 2024 PR Newswire Fri, 20 Sep 2024 13:25:00 GMT

• kin season 3: everything you need to know Digital Spy Fri, 20 Sep 2024 13:20:18 GMT

• knowles (nyse:kn) releases q3 2024 earnings guidance Defense World Fri, 20 Sep 2024 12:52:44 GMT

• kineta, inc transitioning from nasdaq to otc markets StockTitan Thu, 19 Sep 2024 22:23:00 GMT

• kinross gold corp. stock rises thursday, still underperforms market MarketWatch Thu, 19 Sep 2024 20:33:00 GMT

• taking on analysts’ expectations and winning: kinetik holdings inc (kntk) SETE News Thu, 19 Sep 2024 18:12:22 GMT

• ka’s stochastic averages dip: analyzing kineta inc’s stock performance The InvestChronicle Thu, 19 Sep 2024 16:43:56 GMT

• knife river (nyse:knf) sets new 12-month high at $92.27 MarketBeat Thu, 19 Sep 2024 15:56:14 GMT

• inspire investing llc increases position in kinsale capital group, inc. (nyse:knsl) Defense World Thu, 19 Sep 2024 14:22:12 GMT

• kinsale: fantastic business fundamentals are priced-in (nyse:knsl) Seeking Alpha Thu, 19 Sep 2024 14:16:28 GMT

• closing figures: kineta inc (ka)’s negative finish at 0.57, down -30.69 The Dwinnex Thu, 19 Sep 2024 11:08:45 GMT

• kintara announces special meeting for proposed tuhura merger TipRanks Thu, 19 Sep 2024 11:01:37 GMT

• kanabo group (lon:knb) shares up 21.7% Defense World Thu, 19 Sep 2024 10:57:12 GMT

• kinsale capital group, inc. (nyse:knsl) shares sold by federated hermes inc. Defense World Thu, 19 Sep 2024 10:27:20 GMT

• arizona state retirement system invests $209,000 in kiniksa pharmaceuticals, ltd. (nasdaq:knsa) Defense World Thu, 19 Sep 2024 09:00:01 GMT

• stocknews.com upgrades kinross gold (nyse:kgc) to strong-buy Defense World Thu, 19 Sep 2024 05:59:08 GMT

• kntk stock hits 52-week high at $46.35 amid robust growth Investing.com Canada Thu, 19 Sep 2024 05:12:11 GMT

• kinetik (nasdaq:kntk) reaches new 1-year high at $45.74 Defense World Thu, 19 Sep 2024 01:30:38 GMT

• kinross gold corp. stock falls wednesday, underperforms market MarketWatch Wed, 18 Sep 2024 20:33:00 GMT

• specialty insurer kinsale set to keep up its strong growth (nyse:knsl) Seeking Alpha Wed, 18 Sep 2024 19:33:01 GMT

• a deep dive into kintara therapeutics inc (ktra) stock performance The InvestChronicle Wed, 18 Sep 2024 14:42:41 GMT

• kinsale capital group, inc. (nyse:knsl) holdings trimmed by state of new jersey common pension fund d Defense World Wed, 18 Sep 2024 10:10:36 GMT

• bank of new york mellon corp increases stake in kiniksa pharmaceuticals, ltd. (nasdaq:knsa) Defense World Wed, 18 Sep 2024 09:05:49 GMT

• kinsale capital group (nyse:knsl) stock rating lowered by wolfe research Defense World Wed, 18 Sep 2024 06:09:58 GMT

• kn’s latest rating updates from top analysts. Knox Daily Wed, 18 Sep 2024 00:45:10 GMT

• kinsale capital group, inc. (knsl) outperforms broader market: what you need to know Yahoo Finance Tue, 17 Sep 2024 22:15:21 GMT

• kapa ipo news - micro-cap cancer biotech kairos pharma prices ipo at $4 Renaissance Capital Tue, 17 Sep 2024 22:04:24 GMT

• kin returning for a season three 'looking less and less likely' Head Topics Tue, 17 Sep 2024 16:45:30 GMT

• kinross gold co. (nyse:kgc) shares sold by dekabank deutsche girozentrale Defense World Tue, 17 Sep 2024 16:01:20 GMT

• kinsale capital: technology, underwriting excellence create moat (nyse:knsl) Seeking Alpha Tue, 17 Sep 2024 16:01:00 GMT

• ratio revelations: kintara therapeutics inc (ktra)’s financial metrics in the spotlight The Dwinnex Tue, 17 Sep 2024 14:52:42 GMT

• there is no way kintara therapeutics inc (ktra) can keep these numbers up SETE News Tue, 17 Sep 2024 13:27:56 GMT

• kin returning for a season three "looking less and less likely" VIP Magazine - Tue, 17 Sep 2024 09:30:28 GMT

• kiniksa pharmaceuticals, ltd. (nasdaq:knsa) shares sold by acadian asset management llc Defense World Tue, 17 Sep 2024 09:21:06 GMT

• kairos goes public with $6m ipo to fund trials of cancer drug Fierce Biotech Tue, 17 Sep 2024 09:08:01 GMT

• kmt’s latest rating updates from top analysts. Knox Daily Mon, 16 Sep 2024 21:28:34 GMT

• kinross gold corp. stock falls monday, underperforms market MarketWatch Mon, 16 Sep 2024 20:33:00 GMT

• kairos pharma shares drop in first trading day MarketWatch Mon, 16 Sep 2024 17:40:00 GMT

• kairos pharma opens at $4, ipo priced at $4 Investing.com Mon, 16 Sep 2024 17:21:23 GMT

• kairos pharma opens at $4, ipo priced at $4 by investing.com Investing.com UK Mon, 16 Sep 2024 17:18:00 GMT

• kinsale capital cut to peer perform at wolfe on more balanced risk-reward (nyse:knsl) Seeking Alpha Mon, 16 Sep 2024 17:03:26 GMT

• kairos pharma prices 1.55m share ipo at $4/sh by investing.com Investing.com Canada Mon, 16 Sep 2024 15:23:13 GMT

• kinsale capital stock rallies 38.7% ytd: more room for upside? Zacks Investment Research Mon, 16 Sep 2024 14:00:42 GMT

• kintara therapeutics inc (ktra)’s stock price in review: a technical analysis US Post News Mon, 16 Sep 2024 13:18:11 GMT

• kinsale capital stock under pressure with growth deceleration - wolfe research Investing.com India Mon, 16 Sep 2024 07:48:47 GMT

• ashton thomas private wealth llc purchases shares of 5,361 kiniksa pharmaceuticals, ltd. (nasdaq:knsa) Defense World Sat, 14 Sep 2024 10:59:33 GMT

• kennametal (nyse:kmt) downgraded to "hold" at stocknews.com MarketBeat Sat, 14 Sep 2024 09:00:08 GMT

• westlake's non-opioid pain startup latigo gets new leader; ron cooper lands next ceo gig at engene Endpoints News Fri, 26 Jul 2024 07:00:00 GMT

• nima farzan named latigo ceo The Pharma Letter Tue, 23 Jul 2024 07:00:00 GMT

• latigo biotherapeutics appoints nima farzan as chief executive officer, positioning company for rapid growth The Malaysian Reserve Mon, 22 Jul 2024 12:44:03 GMT

• Latigo Biotherapeutics Names New CEO Contract Pharma Mon, 22 Jul 2024 07:00:00 GMT

• thousand oaks biotech company appoints ceo Pacific Coast Business Times Mon, 22 Jul 2024 07:00:00 GMT

• kinnate biopharma inc. reports second quarter 2023 financial results and recent corporate updates Quantisnow Thu, 11 Jul 2024 15:25:25 GMT

• demystifying xoma: insights from 5 analyst reviews Quantisnow Tue, 09 Jul 2024 14:01:08 GMT

• xoma corporation: a hold rating with steady income from preferred shares (nasdaq:xoma) Seeking Alpha Sat, 29 Jun 2024 07:00:00 GMT

• kinnate biopharma gaap eps of -$0.68 beats by $0.08 MSN Wed, 08 May 2024 19:22:31 GMT

• novartis, ono latest to announce billion-dollar m&a deals BioSpace Fri, 03 May 2024 07:30:41 GMT

• novartis, ono latest to announce billion-dollar m&a deals BioSpace Thu, 02 May 2024 07:00:00 GMT

• daré bioscience raises $22 million by licensing royalties | pharmaceutical | the pharmaletter | the pharmaletter The Pharma Letter Thu, 02 May 2024 07:00:00 GMT

• harmony, ono, incyte lead late april m&a uptick BioSpace Wed, 01 May 2024 08:17:52 GMT

• harmony, ono, incyte lead late april m&a uptick BioSpace Tue, 30 Apr 2024 07:00:00 GMT

• $2.4b ono purchase of deciphera highlights recent m&a activity BioSpace Tue, 30 Apr 2024 06:54:03 GMT

• $2.4b ono purchase of deciphera highlights recent m&a activity BioSpace Mon, 29 Apr 2024 23:09:45 GMT

• kinnate biopharma inc. (nasdaq:knte) given average recommendation of “hold” by analysts Defense World Fri, 26 Apr 2024 07:10:09 GMT

• artiva biotherapeutics readies for the next phase of growth with the appointment of neha krishnamohan as cfo and evp, corporate de... Business Wire Thu, 25 Apr 2024 07:00:00 GMT

• should you buy kinnate biopharma (knte) ahead of earnings? AOL Thu, 25 Apr 2024 00:38:22 GMT

• incyte breaks mid-april m&a lull with escient purchase BioSpace Wed, 24 Apr 2024 06:55:30 GMT

• incyte breaks mid-april m&a lull with escient purchase BioSpace Tue, 23 Apr 2024 07:00:00 GMT

• should you buy kinnate biopharma (knte) ahead of earnings? Yahoo Canada Shine On Sun, 14 Apr 2024 12:54:37 GMT

• should you buy kinnate biopharma (knte) ahead of earnings? Yahoo Canada Shine On Sat, 13 Apr 2024 03:36:00 GMT

• $4.9b vertex-alpine deal highlights continued 2024 m&a upswing BioSpace Fri, 12 Apr 2024 06:49:37 GMT

• $4.9b vertex-alpine deal highlights continued 2024 m&a upswing BioSpace Thu, 11 Apr 2024 07:00:00 GMT

• merck, essential pharma, corerx and more continue 2024 m&a upswing BioSpace Tue, 09 Apr 2024 07:00:00 GMT

• merck, genmab, kintara and more continue 2024 m&a upswing BioSpace Mon, 08 Apr 2024 07:00:00 GMT

• genmab, kintara, ginkgo and more continue 2024 m&a upswing BioSpace Thu, 04 Apr 2024 09:44:53 GMT

• kinnate biopharma's strategic shift and corporate evolution - tipranks.com TipRanks Wed, 03 Apr 2024 13:44:51 GMT

• kinnate biopharma’s strategic shift and corporate evolution TipRanks Wed, 03 Apr 2024 13:44:51 GMT

• XOMA Corporation Announces Closing of Tender Offer GlobeNewswire Wed, 03 Apr 2024 07:00:00 GMT

• fierce biotech's quarterly ipo and m&a roundup: q1'24 Fierce Biotech Wed, 03 Apr 2024 07:00:00 GMT

• xoma announces closing of tender offer TipRanks Wed, 03 Apr 2024 07:00:00 GMT

• xoma announces closing of tender offer - tipranks.com TipRanks Wed, 03 Apr 2024 07:00:00 GMT

• genmab, kintara, ginkgo and more continue 2024 m&a upswing BioSpace Wed, 03 Apr 2024 07:00:00 GMT

• kinnate biopharma inc. (nasdaq:knte) given average rating of "hold" by brokerages MarketBeat Tue, 02 Apr 2024 01:58:36 GMT

• brokerages set kinnate biopharma inc. (nasdaq:knte) price target at $11.72 MarketBeat Mon, 01 Apr 2024 22:41:15 GMT

• Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies Fierce Pharma Mon, 01 Apr 2024 07:00:00 GMT

• kinnate biopharma inc. (nasdaq:knte) given average rating of "hold" by brokerages MarketBeat Mon, 01 Apr 2024 07:00:00 GMT

• kinnate biopharma inc. (nasdaq:knte) receives average recommendation of “hold” from analysts Defense World Mon, 01 Apr 2024 07:00:00 GMT

• kinnate biopharma inc reports results for the quarter ended in december - earnings summary TradingView Fri, 29 Mar 2024 19:05:36 GMT

• 2024 m&a upswing continues with avalo, gilead, immunome buys BioSpace Fri, 29 Mar 2024 07:00:00 GMT

• kinnate biopharma inc. (nasdaq:knte) sees significant decline in short interest MarketBeat Thu, 28 Mar 2024 23:04:37 GMT

• kinnate biopharma inc. (nasdaq:knte) short interest down 43.6% in march MarketBeat Thu, 28 Mar 2024 14:32:03 GMT

• 2024 m&a upswing continues with gilead, immunome, novo buys BioSpace Thu, 28 Mar 2024 07:00:00 GMT

• novo, abbvie, lonza boost portfolios, manufacturing as part of 2024 m&a upswing BioSpace Mon, 25 Mar 2024 21:32:22 GMT

• 2024-03-25 | ndaq:knte | press release | kinnate biopharma inc Stockhouse Publishing Mon, 25 Mar 2024 19:36:11 GMT

• brodsky & smith shareholder update: notifying investors of GlobeNewswire Mon, 25 Mar 2024 07:00:00 GMT

• citigroup inc. purchases 419,795 shares of kinnate biopharma inc. (nasdaq:knte) MarketBeat Sat, 23 Mar 2024 03:10:54 GMT

• citigroup inc. purchases 419,795 shares of kinnate biopharma inc. (nasdaq:knte) MarketBeat Fri, 22 Mar 2024 08:38:29 GMT

• citigroup inc. buys 419,795 shares of kinnate biopharma inc. (nasdaq:knte) MarketBeat Fri, 22 Mar 2024 08:38:29 GMT

• kinnate biopharma inc. (nasdaq:knte) shares purchased by citigroup inc. MarketBeat Fri, 22 Mar 2024 08:38:29 GMT

• citigroup inc. increases position in kinnate biopharma inc. (nasdaq:knte) MarketBeat Fri, 22 Mar 2024 08:38:29 GMT

• citigroup inc. buys 419795 shares of kinnate biopharma inc. (nasdaq:knte) Defense World Fri, 22 Mar 2024 07:00:00 GMT

• shareholder update: halper sadeh llc investigates free, sctl, knte EIN News Wed, 20 Mar 2024 12:14:34 GMT

• XOMA Announces Calculation of Additional Price Per Share GlobeNewswire Tue, 19 Mar 2024 07:00:00 GMT

• brodsky & smith shareholder update: notifying investors of the following investigations: fusion ... GlobeNewswire Tue, 19 Mar 2024 07:00:00 GMT

• az-fusion deal, bms $14b karuna purchase highlight 2024 m&a upswing BioSpace Tue, 19 Mar 2024 07:00:00 GMT

• kinnate biopharma (knte) earnings date and reports 2024 MarketBeat Sun, 17 Mar 2024 13:40:41 GMT

• novartis, merck, j&j add to 2024 m&a upswing BioSpace Fri, 15 Mar 2024 07:20:20 GMT

• astrazeneca, novartis, merck add to 2024 m&a upswing BioSpace Fri, 15 Mar 2024 07:00:00 GMT

• novartis, merck, j&j add to 2024 m&a upswing BioSpace Thu, 14 Mar 2024 20:47:35 GMT

• brodsky & smith shareholder update: notifying investors of the following investigations: whole earth ... GlobeNewswire Wed, 13 Mar 2024 07:00:00 GMT

• kinnate biopharma investor alert by the former attorney general of louisiana: kahn swick ... Business Wire Wed, 13 Mar 2024 07:00:00 GMT

• shareholder update: halper sadeh llc investigates knte, door, hmst ForexTV.com Wed, 13 Mar 2024 07:00:00 GMT

• merck, j&j add to 2024 m&a upswing BioSpace Tue, 12 Mar 2024 17:00:01 GMT

• kinnate biopharma (knte) to release quarterly earnings on wednesday MarketBeat Tue, 12 Mar 2024 07:00:00 GMT

• j&j adds to 2024 m&a upswing BioSpace Tue, 12 Mar 2024 04:41:46 GMT

• j&j adds to 2024 m&a upswing BioSpace Mon, 11 Mar 2024 19:08:43 GMT

• biopharma mergers and acquisitions continue to trend upward in 2024 BioSpace Mon, 11 Mar 2024 12:02:13 GMT

• connor clark & lunn investment management ltd. acquires new shares in kinnate biopharma inc. (nasdaq:knte) American Banking News Sat, 09 Mar 2024 08:00:00 GMT

• investigation: the m&a class action firm continues investigating the merger – tast, knte, inbx AccessWire Fri, 08 Mar 2024 22:42:47 GMT

• xoma corp (xoma) reports mixed financial results for q4 and full year 2023 Yahoo Finance Fri, 08 Mar 2024 08:00:00 GMT

• kinnate biopharma inc. (nasdaq:knte) given consensus recommendation of “hold” by brokerages Defense World Fri, 08 Mar 2024 00:44:55 GMT

• kinnate biopharma inc. (nasdaq:knte) given consensus recommendation of “hold” by brokerages Defense World Thu, 07 Mar 2024 08:00:00 GMT

• biopharma mergers and acquisitions continue to trend upward in 2024 BioSpace Wed, 06 Mar 2024 04:52:30 GMT

• shareholder update: halper sadeh llc investigates hayn, knte, sctl Victoria Advocate Tue, 05 Mar 2024 23:27:00 GMT

• novartis, ono latest to announce billion-dollar m&a deals BioSpace Tue, 05 Mar 2024 08:00:00 GMT

• kinnate biopharma inc. (nasdaq:knte) stake increased by citigroup inc. MarketBeat Mon, 04 Mar 2024 09:37:14 GMT

• Pierre Fabre SAS in US$31m licence deal with Kinnate Biopharma Inc European Biotechnology Magazine Mon, 04 Mar 2024 08:00:00 GMT

• kinnate biopharma inc. verkauft seinen in der entwicklung befindlichen pan-raf-inhibitor, exarafenib an pierre fabre ... PR Newswire Mon, 04 Mar 2024 08:00:00 GMT

• citigroup inc. has $589000 stock holdings in kinnate biopharma inc. (nasdaq:knte) Defense World Mon, 04 Mar 2024 08:00:00 GMT

• shareholder update: halper sadeh llc investigates aa, ngm, knte ForexTV.com Sat, 02 Mar 2024 16:16:03 GMT

• kinnate biopharma inc. sells its investigational pan-raf inhibitor, exarafenib, to pierre fabre laboratories The Malaysian Reserve Sat, 02 Mar 2024 02:25:10 GMT

• kinnate sells pan-raf inhibitor assets to pierre fabre The Pharma Letter Fri, 01 Mar 2024 16:12:21 GMT

• kinnate bio rises after selling a cancer therapy to pierre fabre XM Fri, 01 Mar 2024 14:40:38 GMT

• kinnate biopharma strikes major deal on drug rights - tipranks.com TipRanks Fri, 01 Mar 2024 14:13:26 GMT

• latest headlines from pr newswire on 5 dariya news 5 Dariya News Fri, 01 Mar 2024 13:30:00 GMT

• Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, exarafenib, to Pierre Fabre Laboratories PR Newswire Fri, 01 Mar 2024 08:00:00 GMT

• Kinnate Biopharma Sells Investigational Pan-RAF Inhibitor to Pierre Fabre Laboratories Contract Pharma Fri, 01 Mar 2024 08:00:00 GMT

• achieve life sciences nabs $124m; pierre fabre buys pan-raf program from kinnate Endpoints News Fri, 01 Mar 2024 08:00:00 GMT

• shareholder alert: levi & korsinsky, llp notifies investors GlobeNewswire Fri, 01 Mar 2024 08:00:00 GMT

• kinnate biopharma sells exarafenib assets to pierre fabre labs MarketWatch Fri, 01 Mar 2024 08:00:00 GMT

• kinnate biopharma sells exarafenib to pierre fabre laboratories - tipranks.com TipRanks Fri, 01 Mar 2024 08:00:00 GMT

• pierre fabre acquires oncology assets from kinnate by investing.com Investing.com Fri, 01 Mar 2024 08:00:00 GMT

• acadian asset management llc raises holdings in kinnate biopharma inc. (nasdaq:knte) MarketBeat Fri, 01 Mar 2024 00:56:13 GMT

• acadian asset management llc has $1.03 million position in kinnate biopharma inc. (nasdaq:knte) Defense World Thu, 29 Feb 2024 12:12:16 GMT

• acadian asset management llc raises holdings in kinnate biopharma inc. (nasdaq:knte) American Banking News Thu, 29 Feb 2024 08:00:00 GMT

• kinnate biopharma inc. (knte) upgraded to buy: what does it mean for the stock? Yahoo Finance Wed, 28 Feb 2024 08:00:00 GMT

• it is poised to be a bull market for kinnate biopharma inc (knte) SETE News Tue, 27 Feb 2024 18:55:22 GMT

• knte stock quote price and forecast CNN Tue, 27 Feb 2024 10:53:04 GMT

• kinnate biopharma (nasdaq:knte) price target raised to $2.59 Defense World Tue, 27 Feb 2024 10:30:39 GMT

• stifel nicolaus raises kinnate biopharma (nasdaq:knte) price target to $2.59 AmericanBankingNEWS Tue, 27 Feb 2024 09:41:41 GMT

• stifel nicolaus boosts kinnate biopharma (nasdaq:knte) price target to $2.59 AmericanBankingNEWS Tue, 27 Feb 2024 09:41:41 GMT

• kinnate biopharma (nasdaq:knte) given new $2.59 price target at stifel nicolaus Defense World Tue, 27 Feb 2024 09:41:31 GMT

• stifel nicolaus increases kinnate biopharma (nasdaq:knte) price target to $2.59 AmericanBankingNEWS Tue, 27 Feb 2024 09:40:57 GMT

• kinnate biopharma (nasdaq:knte) price target increased to $2.59 by analysts at stifel nicolaus American Banking News Tue, 27 Feb 2024 08:00:00 GMT

• stifel nicolaus increases kinnate biopharma (nasdaq:knte) price target to $2.59 MarketBeat Mon, 26 Feb 2024 15:19:46 GMT

• stifel nicolaus raises kinnate biopharma (nasdaq:knte) price target to $2.59 MarketBeat Mon, 26 Feb 2024 15:19:46 GMT

• kinnate biopharma (nasdaq:knte) pt raised to $2.59 at stifel nicolaus MarketBeat Mon, 26 Feb 2024 15:19:46 GMT

• kinnate biopharma (nasdaq:knte) given new $2.59 price target at stifel nicolaus MarketBeat Mon, 26 Feb 2024 15:19:46 GMT

• stifel nicolaus boosts kinnate biopharma (nasdaq:knte) price target to $2.59 MarketBeat Mon, 26 Feb 2024 15:19:46 GMT

• thinking about buying stock in idaho strategic resources, angi, alarm.com, kinnate biopharma, or quanta services? PrimePublishers.com Mon, 26 Feb 2024 14:31:00 GMT

• brodsky & smith shareholder update: notifying investors of the following investigations: avrobio, inc ... GlobeNewswire Mon, 26 Feb 2024 08:00:00 GMT

• kinnate biopharma (nasdaq:knte) price target increased to $2.59 by analysts at stifel nicolaus MarketBeat Mon, 26 Feb 2024 08:00:00 GMT

• kinnate acquires ownership stake in china joint venture kinnjiu in $24m cash/stock deal MSN Thu, 22 Feb 2024 00:46:27 GMT

• xoma's acquisition of kinnate biopharma – global legal chronicle Global Legal Chronicle Thu, 22 Feb 2024 00:00:00 GMT

• xoma’s acquisition of kinnate biopharma Global Legal Chronicle Thu, 22 Feb 2024 00:00:00 GMT

• shareholder update: halper sadeh llc investigates dfs, cof, knte Longview News-Journal Wed, 21 Feb 2024 15:13:00 GMT

• brodsky & smith shareholder update: notifying investors of the following investigations: vizio holding corp. (nyse – vzio), hireri... ForexTV.com Wed, 21 Feb 2024 00:15:54 GMT

• Wilson Sonsini Advises Kinnate Biopharma on Acquisition By XOMA Wilson Sonsini Tue, 20 Feb 2024 08:00:00 GMT

• brodsky & smith shareholder update: notifying investors of the following investigations: vizio holding corp ... CW33 Dallas Tue, 20 Feb 2024 08:00:00 GMT

• shareholder update: halper sadeh llc investigates knte, ctlt ForexTV.com Tue, 20 Feb 2024 02:18:13 GMT

• upper peninsula abc 10 - news, sports, weather and more from michigan's upper peninsula FinancialContent Mon, 19 Feb 2024 08:00:00 GMT

• kinnate biopharma investor alert by the former attorney general of louisiana: kahn swick & foti, llc ... Business Wire Mon, 19 Feb 2024 08:00:00 GMT

• xoma to acquire kinnate biopharma The Pharma Letter Sat, 17 Feb 2024 08:00:00 GMT

• xoma to acquire kinnate biopharma | the pharmaletter The Pharma Letter Sat, 17 Feb 2024 08:00:00 GMT

• private equity firms who hold 45% of kinnate biopharma inc. (nasdaq:knte) gained 11%, institutions profited as well Yahoo Finance Sat, 17 Feb 2024 08:00:00 GMT

• 2024-02-17 | ndaq:ionm | press release | assure holdings corp Stockhouse Publishing Sat, 17 Feb 2024 08:00:00 GMT

• shareholder update: halper sadeh llc investigates knte, free, ionm AccessWire Sat, 17 Feb 2024 08:00:00 GMT

• xoma to acquire kinnate biopharma for between $2.3352-$2.5879 per share plus cvr - tipranks.com TipRanks Sat, 17 Feb 2024 03:03:51 GMT

• alert: rowley law pllc is investigating proposed acquisition of kinnate biopharma inc. MENAFN.COM Fri, 16 Feb 2024 23:00:44 GMT

• shareholder update: halper sadeh llc investigates hrt, knte, calb Longview News-Journal Fri, 16 Feb 2024 20:45:00 GMT

• kinnate hikes on merger with xoma Baystreet.ca Fri, 16 Feb 2024 16:56:00 GMT

• 2024-02-16 | ndaq:hayn | press release | haynes international inc Stockhouse Publishing Fri, 16 Feb 2024 15:46:44 GMT

• kinnate biopharma rises as co to be acquired by xoma corp XM Fri, 16 Feb 2024 15:27:21 GMT

• kinnate biopharma's strategic merger with xoma for cancer innovation - tipranks.com TipRanks Fri, 16 Feb 2024 14:23:36 GMT

• XOMA Enters into Agreement to Acquire Kinnate Biopharma for GlobeNewswire Fri, 16 Feb 2024 08:00:00 GMT

• Biotech Royalty Aggregator XOMA To Acquire Small Cancer-Drug Developer Kinnate Biopharma Benzinga Fri, 16 Feb 2024 08:00:00 GMT

• xoma to buy kinnate; a pain biotech’s small ipo Endpoints News Fri, 16 Feb 2024 08:00:00 GMT

• xoma corp secures merger with kinnate biopharma inc. TipRanks Fri, 16 Feb 2024 08:00:00 GMT

• shareholder alert: ademi llp investigates whether kinnate biopharma inc. has obtained a fair price in its transaction with xoma Marketscreener.com Fri, 16 Feb 2024 08:00:00 GMT

• xoma to acquire kinnate biopharma (nasdaq:xoma) Seeking Alpha Fri, 16 Feb 2024 08:00:00 GMT

• xoma to acquire kinnate biopharma for $2.3352 - $2.5879 per share Seeking Alpha Fri, 16 Feb 2024 08:00:00 GMT

• knte stock alert: halper sadeh llc is investigating whether the sale of kinnate biopharma inc. is fair to shareholders businesswire.com Fri, 16 Feb 2024 08:00:00 GMT

• brodsky & smith shareholder update: notifying investors of the following investigations: hireright holdings ... GlobeNewswire Fri, 16 Feb 2024 08:00:00 GMT

• xoma to acquire kinnate biopharma in cash deal Investing.com Fri, 16 Feb 2024 08:00:00 GMT

• kinnate biopharma shares rise on xoma acquisition MarketWatch Fri, 16 Feb 2024 08:00:00 GMT

• xoma agrees to acquire kinnate biopharma MarketWatch Fri, 16 Feb 2024 08:00:00 GMT

• kinnate biopharma inc. enters into agreement to be acquired by xoma corporation for between $2.3352 and $2.5879 ... TradingView Fri, 16 Feb 2024 08:00:00 GMT

• xoma to acquire kinnate biopharma in cash deal by investing.com Investing.com Fri, 16 Feb 2024 08:00:00 GMT

• xoma to acquire kinnate biopharma for between $2.3352-$2.5879 per share plus cvr - tipranks.com TipRanks Fri, 16 Feb 2024 08:00:00 GMT

• xoma to acquire kinnate for between $2.3352-$2.5879 per share plus cvr - tipranks.com TipRanks Fri, 16 Feb 2024 08:00:00 GMT

• kinnate biopharma’s strategic merger with xoma for cancer innovation TipRanks Fri, 16 Feb 2024 08:00:00 GMT

• indo-asian news service-kuehn law encourages knte, fang, hayn, and vine investors to contact ... IANS India Pvt Ltd Fri, 16 Feb 2024 08:00:00 GMT

• xoma corporation and kinnate biopharma inc. merger: a new era in precision oncology BNN Breaking Fri, 16 Feb 2024 08:00:00 GMT

• short interest in kinnate biopharma inc. (nasdaq:knte) increases by 5.8% MarketBeat Fri, 16 Feb 2024 08:00:00 GMT

• xoma and kinnate biopharma merger: a leap forward in precision oncology BNN Breaking Fri, 16 Feb 2024 08:00:00 GMT

• xoma corporation acquires kinnate biopharma: a strategic move in the biopharmaceutical landscape BNN Breaking Fri, 16 Feb 2024 08:00:00 GMT

• super micro computer, kinsale capital, kinnate biopharma TradingView Fri, 16 Feb 2024 08:00:00 GMT

• service-shareholder alert: ademi llp investigates whether kinnate biopharma inc. has ... IANS India Pvt Ltd Fri, 16 Feb 2024 05:57:00 GMT

• indo-asian news service IANS India Pvt Ltd Fri, 16 Feb 2024 05:57:00 GMT

• kinnate biopharma inc. (nasdaq:knte) receives $12.20 average target price from brokerages AmericanBankingNEWS Wed, 14 Feb 2024 08:00:00 GMT

• kinnate biopharma inc. (nasdaq:knte) receives average recommendation of "hold" from brokerages MarketBeat Sun, 11 Feb 2024 08:20:52 GMT

• analysts issue forecasts for kinnate biopharma inc.'s q3 2024 earnings (nasdaq:knte) Defense World Fri, 09 Feb 2024 08:52:27 GMT

• kinnate biopharma inc. to post q1 2024 earnings of ($0.36) per share, leerink partnrs forecasts (nasdaq:knte) Defense World Fri, 09 Feb 2024 08:00:00 GMT

• leerink partnrs weighs in on kinnate biopharma inc.'s q3 2024 earnings (nasdaq:knte) MarketBeat Thu, 08 Feb 2024 08:00:00 GMT

• leerink partnrs comments on kinnate biopharma inc.'s q1 2024 earnings (nasdaq:knte) MarketBeat Wed, 07 Feb 2024 13:29:32 GMT

• analysts issue forecasts for kinnate biopharma inc.'s q2 2024 earnings (nasdaq:knte) MarketBeat Fri, 19 Jan 2024 13:19:27 GMT

• wedbush weighs in on kinnate biopharma inc.'s q1 2024 earnings (nasdaq:knte) Defense World Fri, 19 Jan 2024 06:41:59 GMT

• kinnate biopharma inc. (nasdaq:knte) forecasted to earn q1 2024 earnings of ($0.41) per share MarketBeat Fri, 19 Jan 2024 05:59:16 GMT

• kinnate biopharma inc. (nasdaq:knte) forecasted to earn q1 2024 earnings of ($0.41) per share MarketBeat Thu, 18 Jan 2024 12:36:08 GMT

• kinnate biopharma inc. (nasdaq:knte) receives average recommendation of "hold" from brokerages MarketBeat Thu, 18 Jan 2024 02:48:22 GMT

• kinnate biopharma inc. (nasdaq:knte) receives average recommendation of "hold" from brokerages MarketBeat Wed, 17 Jan 2024 15:42:09 GMT

• wedbush reiterates "neutral" rating for kinnate biopharma (nasdaq:knte) MarketBeat Wed, 17 Jan 2024 13:47:50 GMT

• The Discovery of Exarafenib (KIN-2787): Overcoming the Challenges of Pan-RAF Kinase Inhibition ACS Publications Wed, 17 Jan 2024 08:00:00 GMT

• kinnate biopharma inc. (nasdaq:knte) sees large growth in short interest MarketBeat Mon, 15 Jan 2024 02:08:08 GMT

• biopharma layoff tracker 2024: c4, affimed, senti and more cut staff BioSpace Wed, 10 Jan 2024 08:00:00 GMT

• biopharma layoff tracker 2024: intellia, thermo fisher, aera and more cut staff BioSpace Fri, 05 Jan 2024 15:49:08 GMT

• kinnate biopharma sells investigational pan-raf inhibitor to pierre fabre laboratories Contract Pharma Wed, 03 Jan 2024 08:00:00 GMT

• kinnate biopharma inc. (nasdaq:knte) shares sold by barclays plc Defense World Sat, 30 Dec 2023 08:00:00 GMT

• biopharma layoff tracker 2023: aclaris, asher, atara and more cut staff BioSpace Sat, 23 Dec 2023 03:46:00 GMT

• biopharma layoff tracker 2023: aclaris, asher, atara and more cut staff BioSpace Fri, 22 Dec 2023 08:00:00 GMT

• biopharma layoff tracker 2023: aclaris, asher, atara and more cut staff BioSpace Thu, 21 Dec 2023 11:31:01 GMT

• investors in cash trouble should check out kinnate biopharma inc (knte) SETE News Thu, 21 Dec 2023 05:15:00 GMT

• investors in cash trouble should check out kinnate biopharma inc (knte) SETE News Wed, 20 Dec 2023 17:16:25 GMT

• biopharma layoff tracker 2023: aclaris, asher, atara and more cut staff BioSpace Wed, 20 Dec 2023 08:00:00 GMT

• biopharma layoff tracker 2023: atara, reneo, vir and more cut staff BioSpace Wed, 20 Dec 2023 04:50:58 GMT

• biopharma layoff tracker 2023: atara, reneo, vir and more cut staff BioSpace Tue, 19 Dec 2023 19:31:35 GMT

• biopharma layoff tracker 2023: reneo, vir, xellia and more cut staff BioSpace Sat, 16 Dec 2023 05:16:26 GMT

• biopharma layoff tracker 2023: vir, xellia, altamira and more cut staff BioSpace Fri, 15 Dec 2023 08:03:50 GMT

• biopharma layoff tracker 2023: reneo, vir, xellia and more cut staff BioSpace Fri, 15 Dec 2023 08:00:00 GMT

• biopharma layoff tracker 2023: vir, xellia, altamira and more cut staff BioSpace Thu, 14 Dec 2023 22:57:38 GMT

Kinnate Biopharma Inc
(NASDAQ:KNTE)

Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers. It develops KIN-2787, which is a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma...

Website: https://www.kinnate.com/

Founded: 2018

CEO: Nima Farzan

Sector: Healthcare

Industry: Biotechnology

Healthcare

Share this website to your friends

Kinnate Biopharma Inc(NASDAQ:KNTE)

Kinnate Biopharma Inc
(NASDAQ:KNTE)